Skip to main content
News

Lansoprazole Recalled


October 05, 2016

The US Food and Drug Administration (FDA) reported the recall of one lot of lansoprazole delayed-release capsules, USP, 30 mg (NDC 63739-0555-10).

What prompted the Class III recall? The inner packaging incorrectly indicated that the medication was omeprazole.

The impacted lot is #0111295, with an expiration of September 2017.

__________________________________________________________________________________________________________________________________________________________________________

RELATED CONTENT
Massive Recall of Blood Thinners, Antibiotic
Sandoz Recalls Hypotension Med, Vasoconstrictor

_______________________________________________________________________________________________________________________________________________________________________________________________________________________

The products were manufactured by Dr. Reddy’s Laboratories for Mckesson Packaging Services.

 Mckesson Packaging Services just launched a recall of alprazolam because the blister cards did not contain any product information.

In April, Dr. Reddy’s Laboratories launched a recall of zoledronic acid injection due to defective seals.

 

--Stephanie Vaccaro

 

Reference:

US Food and Drug Administration. FDA Enforcement Report – Week of October 5, 2016. www.fda.gov. Accessed October 6, 2016.

 

 

 

Back to Top